Építés alatt – nem éles oldal
Belépés
Toborzás még nem indultFázis nélkül

Lipid Management Gaps in Mexican Patients at High and Very High Cardiovascular Risk

A legfontosabb adatok

Ki végzi
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Hol
Mexikó1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toborzás még nem indult
Résztvevők
1600 fő, tervezett
Kezdés
2027. jan. 1.
Várható befejezés
2029. febr. 28.
A vizsgálat típusa
Megfigyeléses
A vizsgált kezelések
  • Lipid-Lowering Therapy in Routine Clinical Practice
A regiszteradat frissítve
2026. november 12.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 8 feltétel megnézéseKevesebb

Ki vehet részt

  • Adults aged 18 years or older
  • Patients classified as having high or very high cardiovascular risk by their treating physician according to the 2019 European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) clinical risk categories
  • Patients currently receiving lipid-lowering therapy or with a clinical indication for lipid-lowering treatment
  • Availability of a baseline low-density lipoprotein cholesterol (LDL-C) measurement, either directly reported or calculable from a lipid profile obtained within the 12 months preceding enrollment
  • Life expectancy greater than one year, based on the treating physician's clinical judgment
  • Provision of written informed consent

Ki nem vehet részt

  • No formal exclusion criteria are established in the study protocol
  • Participants for whom critical baseline variables, particularly an LDL-C measurement with its corresponding date, cannot be documented will not be eligible for the primary analysis dataset

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

SANTORINI-MX is a nationwide, multicenter, prospective, observational study designed to evaluate cholesterol management among adults in Mexico who are at high or very high risk of cardiovascular disease.

A teljes eredeti leírásKevesebb

The main objective is to determine the proportion of patients who achieve the recommended low-density lipoprotein cholesterol (LDL-C) goals according to the 2019 European Society of Cardiology/European Atherosclerosis Society guidelines.

Approximately 1,600 adults will be enrolled from an initial network of 15 public and private healthcare centers across Mexico. Participants will be evaluated at enrollment and followed for approximately 12 months, with an allowable follow-up window of 10 to 14 months.

The study will collect information on cholesterol levels, cardiovascular risk factors, lipid-lowering medications, treatment changes, medication adherence, and barriers to optimal cholesterol management. Researchers will also examine whether treatment is intensified when LDL-C goals are not achieved.

This is a non-interventional study. Medical treatments and decisions will remain under the responsibility of each participant's treating physician, and no additional medical procedures will be required solely for research purposes.

The findings are expected to help identify gaps in cholesterol management in Mexico and inform future strategies to improve cardiovascular prevention and patient care.

A vizsgálat csoportja

  • High and Very High Cardiovascular Risk Patients

    Adults aged 18 years or older classified as having high or very high cardiovascular risk according to the 2019 ESC/EAS guidelines, who are receiving or have a clinical indication for lipid-lowering therapy. Participants will be consecutively enrolled at participating healthcare centers in Mexico and assessed at baseline and after 12 ± 2 months. Lipid levels, cardiovascular risk factors, lipid-lowering treatments, treatment intensification, medication adherence, and barriers to optimal lipid management will be recorded. All treatments will be prescribed according to routine clinical practice, without protocol-assigned interventions.

    Kezelés: Lipid-Lowering Therapy in Routine Clinical Practice

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
SANTORINI-MX: Lipid Management Gaps in Mexican Patients at High and Very High Cardiovascular Risk
A regiszteradat frissítve
2026. november 12.